Center for Scientific Review; Notice of Closed Meetings, 48105-48106 [2017-22258]

Download as PDF Federal Register / Vol. 82, No. 198 / Monday, October 16, 2017 / Notices Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892–9750, 240–276–6343, schweinfestcw@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 10, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–22246 Filed 10–13–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting ethrower on DSK3G9T082PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Medications Development. Date: November 1, 2017. Time: 8:00 a.m. 5:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814. Contact Person: Ivan K. Navarro, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, Division of Extramural Research, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, Room 4242, MSC 9550, Bethesda, MD 20892, 301–827–5833, ivan.navarro@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) VerDate Sep<11>2014 16:59 Oct 13, 2017 Jkt 244001 Dated: October 10, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–22247 Filed 10–13–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, November 2, 2017, 9:00 a.m. to November 2, 2017, 7:00 p.m., National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 which was published in the Federal Register on September 22, 2017, 82 FR 44429. This meeting notice is amended to change the meeting date from November 2, 2017 to December 7, 2017. The meeting is closed to the public. Dated: October 10, 2017. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–22245 Filed 10–13–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–16– 443: Drug Abuse Dissertation Research. Date: November 1, 2017. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 48105 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Robert Freund, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301–435– 1050, freundr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Nursing and Related Clinical Sciences. Date: November 6, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Xin Yuan, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3141, Bethesda, MD 20892, 301–827–7245, yuanx4@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group; AIDS Clinical Studies and Epidemiology Study Section. Date: November 7–8, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Melrose Hotel, 2430 Pennsylvania Ave. NW., Washington, DC 20037. Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3190, Bethesda, MD 20892, 301–827– 7480, dimitrios.vatakis@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowship: AIDS and AIDS-related Applications. Date: November 7, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3196, Bethesda, MD 20892, 301–451–5953, tuoj@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Epidemiology of Environmental Exposures, Diet, Biomarkers, and Genetics in Chronic Disease. Date: November 7, 2017. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20814, (Telephone Conference Call). Contact Person: George Vogler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3140, MSC 7770, Bethesda, MD 20892, (301) 237– 2693, voglergp@csr.nih.gov. E:\FR\FM\16OCN1.SGM 16OCN1 48106 Federal Register / Vol. 82, No. 198 / Monday, October 16, 2017 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–15– 319: Biomedical and Behavioral Research Innovations to Ensure Equity (BRITE). Date: November 7, 2017. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Jessica Bellinger, Scientific Review Administrator, Center for Scientific of Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301–827–4446, bellingerjd@ csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group; AIDS Immunology and Pathogenesis Study Section. Date: November 9, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 20036. Contact Person: Shiv A. Prasad, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, 301–443– 5779, prasads@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Genomics, Genetic Variation, Gene Transcriptional Regulation and Informatics. Date: November 9, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, 6701 Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301–827–7088, methode.bacanamwo@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 10, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–22258 Filed 10–13–17; 8:45 am] BILLING CODE 4140–01–P ethrower on DSK3G9T082PROD with NOTICES DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2017–0900] Navigation Safety Advisory Council U.S. Coast Guard, Department of Homeland Security. AGENCY: VerDate Sep<11>2014 16:59 Oct 13, 2017 Jkt 244001 Notice of Federal Advisory Committee meeting. ACTION: The Navigation Safety Advisory Council will meet to discuss matters relating to maritime collisions, rammings, and groundings; Inland Rules of the Road; International Rules of the Road; navigation regulations and equipment, routing measures, marine information, diving safety, and aids to navigation systems. These meetings will be open to the public. DATES: The Navigation Safety Advisory Council will meet on Wednesday, November 1, 2017, from 8 a.m. to 5:30 p.m., and on Thursday, November 2, 2017, from 8 a.m. to 5:30 p.m. Please note these meetings may close early if the Council has completed its business. ADDRESSES: The meeting will be held at the Holiday Inn Arlington at Ballston, 4610 Fairfax Drive, Arlington VA 22203. https://www.holidayinn.com/hotels/us/ en/arlington/wasfx/hoteldetail/ directions. For information on facilities or services for individuals with disabilities or to request special assistance at the meeting, contact Mr. Detweiler as soon as possible using the contact information in the FOR FURTHER INFORMATION CONTACT section of this notice. Instructions: You are free to submit comments at any time, including orally at the meetings, but if you want Council members to review your comment before the meetings, please submit your comments no later than October 23, 2017. We are particularly interested in comments on the issues in the ‘‘Agenda’’ section below. You must include ‘‘Department of Homeland Security’’ and the docket number USCG–2017–0900. Written comments may also be submitted using the Federal eRulemaking Portal at https:// www.regulations.gov. If you encounter technical difficulties with comments submission, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section below. Comments received will be posted without alteration at https://www.regulations.gov, including any personal information provided. You may review the Privacy and Security Notice for the Federal Docket Management System at https:// www.regulations.gov/privacyNotice. Docket Search: For access to the docket or to read documents or comments related to this notice, go to https://www.regulations.gov, insert USCG–2017–0900 in the Search box, press enter, and then click on the item you wish to view. FOR FURTHER INFORMATION CONTACT: If you have questions about these SUMMARY: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 meetings, please contact Mr. George Detweiler, the Navigation Safety Advisory Council Alternate Designated Federal Officer, Commandant (CG– NAV–2), U.S. Coast Guard, 2703 Martin Luther King Jr. Avenue SE., Stop 7418, Washington, DC 20593, telephone 202– 372–1566 or email George.H.Detweiler@ uscg.mil. SUPPLEMENTARY INFORMATION: Notice of this meeting is given pursuant to the Federal Advisory Committee Act, Title 5 United States Code, Appendix. The Navigation Safety Advisory Council is an advisory committee authorized under Title 33 United States Code, Section 2073 and chartered under the provisions of the Federal Advisory Committee Act, Title 5, United States Code, Appendix. The Navigation Safety Advisory Council provides advice and recommendations to the Secretary, through the Commandant of the U.S. Coast Guard, on matters relating to maritime collisions, rammings, and groundings; Inland Rules of the Road; International Rules of the Road; navigation regulations and equipment, routing measures, marine information, diving safety, and aids to navigation systems. Agenda Wednesday, November 1, 2017 The Navigation Safety Advisory Council members will receive presentations on the following topics from agency representatives who performed the studies: (1) The Vessel Traffic Service Study conducted by the National Transportation Safety Board; (2) The Atlantic and Gulf Coast Seacoast Waterways and Analysis Management System Study being conducted by the Coast Guard; and (3) Use of Automatic Identification System-Aids and Navigation in PreStorm Preparations and Post Storm Recovery. Following the above presentations, the Designated Federal Officer will form subcommittees to continue discussions on the following task statements: (1) Navigation Safety Advisory Council Task 16–01 Review the navigation safety consequences of ships using Ultra Low Sulphur Fuel Oil and recommend measures to mitigate those consequences; (2) Navigation Safety Advisory Council Task 16–02 Develop criteria for reporting ‘‘near miss’’ incidents; and (3) Navigation Safety Advisory Council Task 17–001 Input to Support Regulatory Reform of Coast Guard Regulations under Executive Orders 13771 and 13783. E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 82, Number 198 (Monday, October 16, 2017)]
[Notices]
[Pages 48105-48106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-22258]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-16-443: Drug Abuse Dissertation Research.
    Date: November 1, 2017.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Robert Freund, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435-
1050, freundr@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Nursing and Related Clinical Sciences.
    Date: November 6, 2017.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Xin Yuan, MD, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3141, Bethesda, MD 20892, 301-827-7245, 
yuanx4@csr.nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group; AIDS Clinical Studies and Epidemiology Study Section.
    Date: November 7-8, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Ave. NW., Washington, DC 
20037.
    Contact Person: Dimitrios Nikolaos Vatakis, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3190, Bethesda, MD 20892, 301-
827-7480, dimitrios.vatakis@nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowship: AIDS and AIDS-related Applications.
    Date: November 7, 2017.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3196, Bethesda, MD 20892, 301-451-5953, 
tuoj@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Epidemiology of Environmental Exposures, 
Diet, Biomarkers, and Genetics in Chronic Disease.
    Date: November 7, 2017.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20814, (Telephone Conference Call).
    Contact Person: George Vogler, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3140, MSC 7770, Bethesda, MD 20892, (301) 237-
2693, voglergp@csr.nih.gov.


[[Page 48106]]


    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-15-319: Biomedical and Behavioral Research Innovations to 
Ensure Equity (BRITE).
    Date: November 7, 2017.
    Time: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Jessica Bellinger, Scientific Review 
Administrator, Center for Scientific of Review, National Institutes 
of Health, 6701 Rockledge Drive, Room 3158, Bethesda, MD 20892, 301-
827-4446, bellingerjd@csr.nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group; AIDS Immunology and Pathogenesis Study Section.
    Date: November 9, 2017.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: St. Gregory Hotel, 2033 M Street NW., Washington, DC 
20036.
    Contact Person: Shiv A. Prasad, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 
20892, 301-443-5779, prasads@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Genomics, Genetic Variation, Gene 
Transcriptional Regulation and Informatics.
    Date: November 9, 2017.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, 6701 Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Methode Bacanamwo, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301-
827-7088, methode.bacanamwo@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 10, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-22258 Filed 10-13-17; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.